Zimbabwe has declined a significant American health deal worth 367 million US dollars (272 million pounds) spanning five years due to Washington's request for sensitive biological samples.
This rejection was revealed following a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the deal was "skewed".
An official spokesman has since stated that the US was seeking genetic material for research and commercial purposes while refused to guarantee the benefits from future vaccines.
"We are forced to start the difficult and regrettable process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for continued negotiations to reach a deal acceptable to both sides so the nation's critical HIV treatment initiative can proceed.
Broader Background
This rejection comes after a similar situation in Kenya, where a high court suspended a similar health funding agreement after legal challenges were filed about the safety of citizens' medical information.
After returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had overseen aid for the US government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral deals to boost transparency and responsibility.
According to statements, 16 nations in Africa have to date agreed to these new agreements, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Effectively, our nation would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be available to our citizens if a new disease outbreak emerge."
National Interest and International Frameworks
He also pointed out that the American exit from the global health body and its pursuit of one-on-one deals were undermining systems already established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.
"This mechanism is designed to ensure that when a nation provides its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to further discussions with our US partners on how subsequent co-operation could be designed in a way that respects the independence and dignity of each country."
Health Experts Response
A leading public health body expressed it understood the government's concerns, but recommended that talks must proceed since much of the nation's HIV programmes were funded by international support.
"Where specific concerns arise, including those involving information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," the group said.
The halted deal highlights the continuing tensions between receiving much-needed international aid and safeguarding national sovereignty in an ever more interconnected world.